Leadership is about driving change at scale and requires engaging both hearts and minds. Sally Susman, Executive Vice President and Chief Corporate Affairs Officer at Pfizer, provides insights ...

Two former Pfizer executives published a statement saying they support management as it gets pressured for changes by activist investor Starboard Value. The ex-Pfizer executives, Ian Read and ...

BenchSci, a world leader in AI solutions for preclinical research and drug discovery, today announced that Mikael Dolsten, M.D., Ph.D., has joined its board of directors.

Former Pfizer Inc PFE CEO Ian Read and ex-CFO Frank D’Amelio have decided to distance themselves from the activist campaign led by Starboard Value at the pharmaceutical giant.

Do No Harm sued Pfizer in 2022 over the company's Breakthrough Fellowship Program, which aimed to increase the pipeline of Black, Latino and Native American leaders, arguing it discriminated ...

Pfizer is making these changes in preparation for integrating Seagen once the $43 billion merger closes, expected in late 2023 or early 2024. For now, the two companies are operating independently ...